UNLYF UNILEVER PLC
Price Chart
Executive Summary
McCormick management provided an update on the pending Unilever Foods acquisition at a Deutsche Bank conference, emphasizing integration progress, reaffirmed financial targets (3-5% top-line growth, 23-25% adjusted operating margins by year 3, $600M synergies, mid-to-high teens EPS accretion by year 3), and a mid-2027 expected close. The filing is promotional in nature with no new material financial data or changes to deal terms.
Actionable Insight
Monitor the secondary listing announcement by end of July 2026 and the detailed synergy/growth/TSA updates expected by end of Q3 2026 for signs of execution risk or upside. The mid-2027 close timeline leaves ample room for regulatory and carve-out processes; any delays or antitrust pushback would be negative. The flowback vs. index-buying dynamic is a key technical factor at close.
Key Facts
- McCormick reaffirmed 2026 outlook and expects mid-2027 close for Unilever Foods acquisition.
- Combined company targets 3-5% top-line growth and 23-25% adjusted operating margins by year 3.
- Cost synergies of $600M expected, with 2/3 by year 2 and remainder by year 3.
- EPS accretion guided to mid-to-high teens by year 3 post-synergies; first full year mid-to-high single digits.
- Deleveraging target: at or below 4x at close to 3x within 2 years, with $1.5B-$2B cash for debt paydown in first 2 years.
- Integration planning underway with 20 functional teams, 200+ people, and an integration management office led by Andrew Foust.
- Secondary European listing location to be announced by end of July 2026.
- More detail on target operating model, cost synergies, growth synergies, and TSA plans expected by end of Q3 2026.
- Emerging markets exposure expected to increase from 25% to 40% of combined sales.
- Flowback from UK/European index funds expected to be more than offset by US index buying demand.
- Consumer environment described as weakening with rising gas prices, but categories remain healthy.
- Cost pressures acknowledged; management plans to mitigate via CCI programs, supply chain initiatives, and revenue growth management.
Financial Impact
No new financial data filed; management reaffirmed prior guidance for 3-5% top-line growth, 23-25% adjusted operating margins, $600M synergies, and mid-to-high teens EPS accretion by year 3.
Risk Factors
- Integration complexity and execution risk given the scale of the carve-out and combination.
- Regulatory approval delays or conditions could push back the mid-2027 close timeline.
- Weakening consumer environment and rising cost pressures could pressure near-term standalone performance.
- Flowback from UK/European index funds may not be fully offset by US index buying demand.
- Leverage at close at or below 4x could limit financial flexibility if macro conditions deteriorate.
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001999371-26-011912 |
| Document: 0001999371-26-011912-index-headers.html | 0001999371-26-011912 |
| Document: 0001999371-26-011912-index.html | 0001999371-26-011912 |
| Document: 0001999371-26-011912.txt | 0001999371-26-011912 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
12d ago
|
425
| $55.33 $55.24 | ▼ −0.16% | ▼ −0.56% | $57.60 (+4.10%) |
|
Jun 1, 2026
13d ago
|
6-K
| $55.21 $55.35 | ▲ +0.25% | ▲ +0.10% | $57.60 (+4.33%) |
|
May 1, 2026
6w ago
|
6-K
| $60.15 $58.34 | ▼ −3.01% | ▼ −2.67% | $57.60 (−4.24%) |
|
Apr 15, 2026
8w ago
|
425
| $57.50 $57.17 | ▼ −0.57% | ▼ −0.83% | $57.60 (+0.17%) |
|
Apr 10, 2026
9w ago
|
425
| $58.11 $57.32 | ▼ −1.36% | ▼ −2.34% | $57.60 (−0.88%) |
|
Apr 6, 2026
9w ago
|
425
| $56.00 $55.71 | ▼ −0.52% | ▼ −0.58% | $57.60 (+2.86%) |
|
Apr 1, 2026
10w ago
|
425
| $55.28 $55.38 | ▲ +0.18% | ▲ +0.10% | $57.60 (+4.20%) |
|
Apr 1, 2026
10w ago
|
425
| $55.28 $55.38 | ▲ +0.18% | ▲ +0.10% | $57.60 (+4.20%) |
|
Apr 1, 2026
10w ago
|
425
| $55.28 $55.38 | ▲ +0.18% | ▲ +0.10% | $57.60 (+4.20%) |
|
Apr 1, 2026
10w ago
|
425
| $55.28 $55.38 | ▲ +0.18% | ▲ +0.10% | $57.60 (+4.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access